{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:21:41Z","timestamp":1790475701350,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.maturitas.2004.03.016","type":"journal-article","created":{"date-parts":[[2004,9,8]],"date-time":"2004-09-08T10:33:15Z","timestamp":1094639595000},"page":"78-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Levonorgestrel and 17\u03b2-estradiol given transdermally for the prevention of postmenopausal osteoporosis"],"prefix":"10.1016","volume":"50","author":[{"given":"L.","family":"Warming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ravn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2004.03.016_BIB1","doi-asserted-by":"crossref","unstructured":"The writing group for the PEPI trial. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen\/progestin interventions (PEPI) trial. The Writing Group for the PEPI. JAMA 1996;276(17):1389\u201396.","DOI":"10.1001\/jama.1996.03540170033029"},{"issue":"13","key":"10.1016\/j.maturitas.2004.03.016_BIB2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","article-title":"Risk of endometrial cancer following estrogen replacement with and without progestins","volume":"91","author":"Weiderpass","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"Suppl 1","key":"10.1016\/j.maturitas.2004.03.016_BIB3","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0020-7292(97)00188-4","article-title":"Quality of life and patient preference for sequential versus continuous combined HRT: the UK Kliofem multicenter study experience. UK continuous combined HRT study investigators","volume":"59","author":"Ulrich","year":"1997","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.maturitas.2004.03.016_BIB4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-5122(95)00949-3","article-title":"17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy","volume":"23","author":"Stadberg","year":"1996","journal-title":"Maturitas"},{"issue":"Suppl 3","key":"10.1016\/j.maturitas.2004.03.016_BIB5","first-page":"273","article-title":"Balancing safety and efficacy focus on endometrial protection","volume":"45","author":"Boroditsky","year":"2000","journal-title":"J. Reprod. Med."},{"issue":"1","key":"10.1016\/j.maturitas.2004.03.016_BIB6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/med.2610110105","article-title":"Transdermal delivery of levonorgestrel","volume":"11","author":"Friend","year":"1991","journal-title":"Med. Res. Rev."},{"issue":"6","key":"10.1016\/j.maturitas.2004.03.016_BIB7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1742-1241.1999.tb11775.x","article-title":"Current hormone replacement therapy: what are the shortcomings? Advances in delivery","volume":"53","author":"Sturdee","year":"1999","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.maturitas.2004.03.016_BIB8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0889-8545(21)00583-0","article-title":"Nonoral routes of estrogen administration","volume":"14","author":"Cedars","year":"1987","journal-title":"Obstet. Gynecol. Clin. North Am."},{"issue":"2","key":"10.1016\/j.maturitas.2004.03.016_BIB9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/jcem-73-2-275","article-title":"Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure","volume":"73","author":"Steingold","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2004.03.016_BIB10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5122(02)00030-0","article-title":"Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel","volume":"42","author":"Paoletti","year":"2002","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.maturitas.2004.03.016_BIB11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1471-0528.1979.tb11263.x","article-title":"A randomized double-blind trial of two low dose combined oral contraceptives","volume":"86","author":"Bounds","year":"1979","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"3","key":"10.1016\/j.maturitas.2004.03.016_BIB12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00042192-200205000-00008","volume":"9","author":"Shulman","year":"2002","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.maturitas.2004.03.016_BIB13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s001980200010","article-title":"Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial","volume":"13","author":"Arrenbrecht","year":"2002","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.maturitas.2004.03.016_BIB14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/PL00004180","article-title":"A combination of low doses of 17 beta-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.maturitas.2004.03.016_BIB15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S8756-3282(02)00678-6","article-title":"Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent","volume":"30","author":"Bjarnason","year":"2002","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.maturitas.2004.03.016_BIB16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/cmt.5.1.45.59","article-title":"The assessment of bleeding patterns in postmenopausal women during continuous combined hormone replacement therapy: a review of methodology and recommendations for reporting of the data","volume":"5","author":"Archer","year":"2002","journal-title":"Climacteric"},{"issue":"2","key":"10.1016\/j.maturitas.2004.03.016_BIB17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/13697139809085528","article-title":"Amenorrhea frequency with continuous combined hormone replacement therapy: a retrospective analysis. Menopause study group","volume":"1","author":"Pickar","year":"1998","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.maturitas.2004.03.016_BIB18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0378-5122(01)00297-3","article-title":"Efficacy of a new 7-day transdermal sequential estradiol\/levonorgestrel patch in women","volume":"41","author":"Von Holst","year":"2002","journal-title":"Maturitas"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512204001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512204001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:38:50Z","timestamp":1759912730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512204001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0378512204001628"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2004.03.016","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levonorgestrel and 17\u03b2-estradiol given transdermally for the prevention of postmenopausal osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2004.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}